Riskpilot← Back to searchSign inGet full accessAndRad AB
ABActiveOrg 5593140444Blommensbergsvägen 112 Lgh 1202Medical specialists activities · NACE 8622Est. 20210 employees
Revenue 2025
SEK 416K
+21% vs 2024
EBITDA margin
81.9%
+70% vs 2024
Equity ratio
74.9%
Financial strength
Net profit 2025
SEK 270K
+70% vs 2024
| Revenue | SEK 416K | +21% |
| EBITDA | SEK 341K | +70% |
| Net profit | SEK 270K | +70% |
| Total assets | SEK 395K | +40% |
| Equity | SEK 296K | +43% |
| Employees | 0 | — |
Legal name
AndRad AB
Org number
5593140444
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 april 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Ska erbjuda konsulttjänster i form av läkare, företrädesvis inom radiologi men kan även var inom andra fält såsom allmänläkarvård eller konsulttjänster till t.ex. läkemedelsbolag eller medicintekniska företag. Uppdrag främst i alla delar av Sverige, men kan även bli aktuellt i övriga Skandinavien eller möjligtvis övriga delar av Europa samt därmed förenlig verksamhet.
Address
Blommensbergsvägen 112 Lgh 1202
Email
andy.lindholm@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 72 | 293 | 341 | 344 | 416 |
| Staff expenses | — | −8 | −9 | −34 | −32 |
| EBITDA | 52 | 235 | 289 | 200 | 341 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 52 | 235 | 289 | 200 | 341 |
| Net financials | — | 0 | 0 | 0 | −0 |
| Profit before tax | 52 | 235 | 289 | 201 | 340 |
| Tax | −11 | −48 | −60 | −41 | −70 |
| Net profit | 41 | 187 | 229 | 159 | 270 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 77 | 321 | 379 | 282 | 395 |
| Equity | 66 | 253 | 287 | 206 | 296 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 11 | 68 | 92 | 75 | 99 |
| Total debt | 11 | 68 | 92 | 75 | 99 |
EBITDA margin
81.9%
This company
15.8%
Market median
+418% vs market
20212025
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
91.4%
This company
18.4%
Market median
+397% vs market
20212025
Net profit margin
65.0%
This company
8.1%
Market median
+702% vs market
20212025
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AP Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AndRad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Philip Lindholm | Chief Executive Officer | 0 companies |
| Lena Gesine Meltzer | Deputy Board Member | 0 companies |